Towards an oral influenza vaccine: Comparison between intragastric and intracolonic delivery of influenza subunit vaccine in a murine model

This publication has 50 references indexed in Scilit:

• Phase I Evaluation of Intranasal Trivalent Inactivated Influenza Vaccine with Nontoxigenic Escherichia coli Enterotoxin and Novel Biovector as Mucosal Adjuvants, Using Adult Volunteers
  Journal of Virology, 2006
• The virosome concept for influenza vaccines
  Vaccine, 2005
• Comparison of single versus booster dose of influenza vaccination on humoral and cellular immune responses in older adults
  Vaccine, 2005
• Oral Administration of Influenza Vaccine in Combination with the Adjuvants LT-K63 and LT-R72 Induces Potent Immune Responses Comparable to or Stronger than Traditional Intramuscular Immunization
  Clinical and Diagnostic Laboratory Immunology, 2001
• Nasal or intramuscular immunization of mice with influenza subunit antigen and the B subunit of Escherichia coli heat-labile toxin induces IgA- or IgG-mediated protective mucosal immunity
  Vaccine, 2001
• Correlates of Immune Protection Induced by Live, Attenuated, Cold‐Adapted, Trivalent, Intranasal Influenza Virus Vaccine
  The Journal of Infectious Diseases, 2000
• Towards an oral influenza vaccine
  Trends in Biotechnology, 1997
• ANTIGEN SAMPLING ACROSS EPITHELIAL BARRIERS AND INDUCTION OF MUCOSAL IMMUNE RESPONSES
  Annual Review of Immunology, 1996
• Cytoplasmic high‐level expression of a soluble, enzymatically active form of the Escherichia coli penicillin‐binding protein 5 and purification by dye chromatography
  European Journal of Biochemistry, 1992
• The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses
  Epidemiology and Infection, 1972